Page last updated: 2024-08-23
5,7-dihydroxytryptamine and Basal Ganglia Diseases
5,7-dihydroxytryptamine has been researched along with Basal Ganglia Diseases in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Guerra, MJ; Labandeira-Garcia, JL; Muñoz, AM; Parga, J; Rey, P | 1 |
Other Studies
1 other study(ies) available for 5,7-dihydroxytryptamine and Basal Ganglia Diseases
Article | Year |
---|---|
Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage.
Topics: 5,7-Dihydroxytryptamine; Afferent Pathways; Animals; Astrocytes; Basal Ganglia Diseases; Biomarkers; Corpus Striatum; Denervation; Dopamine; Female; Gliosis; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Ibotenic Acid; Immunohistochemistry; Microglia; Nerve Degeneration; Neuroglia; Neurotoxins; Oxidopamine; Oxygenases; Rats; Rats, Sprague-Dawley; Serotonin | 2005 |